Horizon Pharma | HZNP - Stock


Horizon Pharma reported $169.56M in Stock for its fiscal quarter ending in December of 2022.



Stock Change Date
AbbVie USD 4.95B 13M Dec/2025
ALKERMES USD 336.7M 140.08M Mar/2026
Amgen USD 6.19B 39M Mar/2026
AstraZeneca USD 6.57B 13M Mar/2026
Bausch Health Companies USD 1.63B 31M Dec/2025
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Cara Therapeutics USD 900K 0 Mar/2025
Coherus Biosciences USD 3.17M 1.12M Dec/2025
Eli Lilly USD 14.53B 785M Mar/2026
Merck USD 6.48B 179M Mar/2026
Novartis USD 6.29B 17M Mar/2026
Pacira USD 150.37M 2.49M Mar/2026
Perrigo USD 1.12B 27.6M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
Prestige Brands USD 163.59M 4.6M Dec/2025
Supernus Pharmaceuticals USD 110.77M 1.71M Mar/2026
Takeda JPY 1.41T 107.71B Dec/2025
Xeris Pharmaceuticals USD 74.23M 5.56M Mar/2026
Zoetis USD 2.55B 120M Mar/2026